The 16-slice CT scanner is expected to appeal to facilities due to a more affordable price point, Siemens said.
The United States Food and Drug Administration (FDA) has approved the SOMATOM Scope, Siemens’ new 16-slice CT scanner.
The SOMATOM Scope is expected to appeal to facilities looking to extend routine diagnostic imaging services to more patients and in more specialty settings largely because of its price point, a release said. Siemens claims that the SOMATOM Scope delivers image quality, dose reduction, and workflow-enhancing benefits “long associated” with the SOMATOM family of CT scanners.
The SOMATOM Scope includes eCockpit technology, which Siemens explains, extends the scanner’s operational lifetime by minimizing wear and tear on the most vital components of the machine. The SOMATOM Scope was designed for facilities large and small and veterinary medicine. The SOMATOM Scope comes in two configurations, which enables providers to comply with the NEMA XR-29 Smart Dose Standard and ensures a safer imaging experience for patients, a release said.
The SOMATOM Scope Power, the more robust scanner, features a stronger X-ray tube, higher performance generator, and faster rotation speeds, making it ideal for higher volume clinical settings, a release said. The SOMATOM Scope utilizes Siemens’ iterative reconstruction in image space (IRIS) technology, which Siemens claims accelerates image reconstruction while reducing noise and artifacts. The SOMATOM Scope also includes Siemens’ fully assisting scanner technology (FAST) and combined applications to reduce exposure (CARE) applications that help reduce radiation exposure and standardize the CT imaging process, Siemens said.
[[{"type":"media","view_mode":"media_crop","fid":"27860","attributes":{"alt":"","class":"media-image media-image-right","id":"media_crop_155778324697","media_crop_h":"0","media_crop_image_style":"-1","media_crop_instance":"2765","media_crop_rotate":"0","media_crop_scale_h":"0","media_crop_scale_w":"0","media_crop_w":"0","media_crop_x":"0","media_crop_y":"0","style":"margin: 1px; border-style: solid; line-height: 1.538em; height: 147px; width: 200px; float: right;","title":"Siemens' SOMATOM Scope CT Scanner","typeof":"foaf:Image"}}]]
Siemens lauds the energy saving aspects of the SOMATOM Scope, which include low heat emissions, a low space requirement of about 130 square feet, and an eSleep mode, which puts the gantry into eSleep mode during periods of extended inactivity.
“By adding the Scope to our portfolio of SOMATOM CT scanners, we help bring CT imaging closer to the point of care, enabling our customers to focus on what matters the most: improving care through more informed, timely clinical decision-making,” Murat Gungor, vice president, computed tomography and radiation oncology business management at Siemens Healthcare, said in a release. “The SOMATOM Scope helps to ensure that a greater segment of the patient population has access to innovative technologies while enabling facilities to help control costs as well as save time and effort throughout their daily routine.”
What is the Best Use of AI in CT Lung Cancer Screening?
April 18th 2025In comparison to radiologist assessment, the use of AI to pre-screen patients with low-dose CT lung cancer screening provided a 12 percent reduction in mean interpretation time with a slight increase in specificity and a slight decrease in the recall rate, according to new research.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
Can CT-Based AI Radiomics Enhance Prediction of Recurrence-Free Survival for Non-Metastatic ccRCC?
April 14th 2025In comparison to a model based on clinicopathological risk factors, a CT radiomics-based machine learning model offered greater than a 10 percent higher AUC for predicting five-year recurrence-free survival in patients with non-metastatic clear cell renal cell carcinoma (ccRCC).
Could Lymph Node Distribution Patterns on CT Improve Staging for Colon Cancer?
April 11th 2025For patients with microsatellite instability-high colon cancer, distribution-based clinical lymph node staging (dCN) with computed tomography (CT) offered nearly double the accuracy rate of clinical lymph node staging in a recent study.